Moderna stock has surged over 600% in 2026, making it the S&P 500's top performer, driven by a cancer vaccine trial.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
Bitcoin’s recovery faces rising derivatives exposure and $643 million in ETF outflows
FBI confirms North Korea's role in $6 billion Binance hack, asks DeFi community to block BTC, ETH, SOL addresses
SpaceX Stock Fell Below Its IPO Price, But Binance's CZ Is Bullish
18 Years of Satoshi’s Paradox: Can Bitcoin Survive What Comes Next?
Jupiter Lend’s withdrawal liquidity rebounds from near zero to 29 million USDC
Banks are owed $349B by private credit funds that may not be collecting cash from borrowers
Bitcoin's white paper turns 18, and small businesses are still paying for the bailouts it answered
Chainalysis breach exposed customer names, emails and company roles
A stolen iPhone, $14,000 in losses and London's crypto theft problem
Traders are already placing leveraged bets on Anthropic’s IPO using crypto contracts
